Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 55.3% during the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 11,051 shares of the company’s stock after selling 13,645 shares during the period. Crossmark Global Holdings Inc.’s holdings in Option Care Health were worth $346,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Atria Investments Inc bought a new stake in shares of Option Care Health during the 3rd quarter worth about $213,000. Villere ST Denis J & Co. LLC increased its stake in shares of Option Care Health by 1.3% during the third quarter. Villere ST Denis J & Co. LLC now owns 1,135,106 shares of the company’s stock valued at $35,529,000 after acquiring an additional 14,439 shares during the period. Harbor Capital Advisors Inc. increased its stake in shares of Option Care Health by 115.4% during the third quarter. Harbor Capital Advisors Inc. now owns 207,560 shares of the company’s stock valued at $6,497,000 after acquiring an additional 111,185 shares during the period. Janney Capital Management LLC bought a new stake in Option Care Health during the third quarter worth approximately $362,000. Finally, Congress Asset Management Co. lifted its position in Option Care Health by 20.9% in the third quarter. Congress Asset Management Co. now owns 341,602 shares of the company’s stock worth $10,692,000 after purchasing an additional 58,972 shares during the period. 98.05% of the stock is currently owned by institutional investors.

Option Care Health Price Performance

NASDAQ OPCH opened at $21.93 on Monday. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 1 year low of $21.64 and a 1 year high of $34.63. The company has a market cap of $3.73 billion, a PE ratio of 18.43, a PEG ratio of 2.27 and a beta of 1.32. The stock’s 50-day moving average price is $28.62 and its two-hundred day moving average price is $29.37.

Analyst Ratings Changes

OPCH has been the topic of several research analyst reports. Truist Financial lowered their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, November 1st. JMP Securities lifted their target price on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a report on Monday, September 30th. Jefferies Financial Group downgraded shares of Option Care Health from a “buy” rating to a “hold” rating and cut their price target for the company from $38.00 to $26.00 in a report on Thursday, October 31st. Bank of America cut shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their price objective for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Finally, The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and cut their target price for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and an average price target of $30.83.

Insider Transactions at Option Care Health

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the transaction, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. The trade was a 69.02 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at $7,654,461.15. The trade was a 8.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.